![]() |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA is alerting health care professionals, patients, and caregivers that Medisca Inc.’s testing of L-citrulline, lot numbers 95482/A, 95482/B, 95482/C, 95482/D and 96453/A, 96453/B, 96453/C, 96453/D, indicated the product does not contain L-citrulline and should not be used by patients. Medisca is voluntarily recalling these lots:
- 1 kg size: Lot #s 96453/A and 95482/A in 2.8 L white HDPE bottles;
- 500 g size: Lot #s 96453/B and 95482/B in 1000 mL white HDPE bottles;
- 100 g size: Lot #s 96453/C and 95482/C in 300 mL white HDPE bottles;
- 25 g size: Lots #s 96453/D and 95482/D in 100 mL white HDPE bottles.
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).


